{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:59:57Z","timestamp":1774889997393,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Clinical Specialty Construction Projects of China","award":["2012\u2013650"],"award-info":[{"award-number":["2012\u2013650"]}]},{"name":"the National Key Clinical Specialty Construction Projects of China","award":["2012\u2013650"],"award-info":[{"award-number":["2012\u2013650"]}]},{"name":"the National Key Clinical Specialty Construction Projects of China","award":["2012\u2013650"],"award-info":[{"award-number":["2012\u2013650"]}]},{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82570131"],"award-info":[{"award-number":["82570131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0529100"],"award-info":[{"award-number":["2024ZD0529100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04157-7","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:45:45Z","timestamp":1771857945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of adherence to sirolimus among lymphangioleiomyomatosis patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Li","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2345-4059","authenticated-orcid":false,"given":"Yating","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8997-9574","authenticated-orcid":false,"given":"Ruoyun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"12","key":"4157_CR1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","volume":"186","author":"FX McCormack","year":"2012","unstructured":"McCormack FX, Travis WD, Colby TV, Henske EP, Moss J. Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. Am J Respir Crit Care Med. 2012;186(12):1210\u20132.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4157_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1164\/rccm.202310-1736LE","volume":"209","author":"E Lynn","year":"2024","unstructured":"Lynn E, Forde SH, Franciosi AN, Bendstrup E, Veltkamp M, Wind AE, Van Moorsel CHM, Lund TK, Durheim MT, Peeters E, et al. Updated prevalence of Lymphangioleiomyomatosis in Europe. Am J Respir Crit Care Med. 2024;209(4):456\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4157_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1164\/rccm.202312-2254ED","volume":"209","author":"N Gupta","year":"2024","unstructured":"Gupta N, Johnson SR. Lymphangioleiomyomatosis: no longer Ultra-rare. Am J Respir Crit Care Med. 2024;209(4):358\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4157_CR4","doi-asserted-by":"publisher","first-page":"C320","DOI":"10.1152\/ajpcell.00202.2022","volume":"324","author":"N Kundu","year":"2023","unstructured":"Kundu N, Holz MK. Lymphangioleiomyomatosis: a metastatic lung disease. Am J Physiol Cell Physiol. 2023;324(2):C320\u20136.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"4157_CR5","doi-asserted-by":"publisher","first-page":"e948947","DOI":"10.1016\/j.urology.2008.01.008","volume":"72","author":"M Kobayashi","year":"2008","unstructured":"Kobayashi M, Nakano K, Nukui A, Goto K, Morita T. Bilateral massive renal Angiomyolipoma concurrent with oncocytoma in tuberous sclerosis complex associated with pulmonary Lymphangioleiomyomatosis. Urology. 2008;72(4):e948947\u2013949.","journal-title":"Urology"},{"issue":"Spec No","key":"4157_CR6","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1148\/radiographics.22.suppl_1.g02oc13s185","volume":"22","author":"E Pallisa","year":"2002","unstructured":"Pallisa E, Sanz P, Roman A, Maj\u00f3 J, Andreu J, C\u00e1ceres J. Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation. Radiographics. 2002;22 Spec No:S185\u201398.","journal-title":"Radiographics"},{"issue":"2","key":"4157_CR7","doi-asserted-by":"publisher","first-page":"00759","DOI":"10.1183\/23120541.00759-2023","volume":"10","author":"MR Oliveira","year":"2024","unstructured":"Oliveira MR, Wanderley M, Freitas CSG, Kairalla RA, Chate RC, Amaral AF, Arimura FE, Samorano LP, Watanabe EH, Carvalho CRR et al. Clinical, tomographic and functional comparison of sporadic and tuberous sclerosis complex-associated forms of lymphangioleiomyomatosis: a retrospective cohort study. ERJ Open Res. 2024;10(2):00759\u20132023.","journal-title":"ERJ Open Res"},{"issue":"5","key":"4157_CR8","doi-asserted-by":"publisher","first-page":"102123","DOI":"10.1016\/j.clgc.2024.102123","volume":"22","author":"J Bellmunt","year":"2024","unstructured":"Bellmunt J, Maroto P, Bonfill T, Vazquez F, Perez-Gracia JL, Juanpere N, Hernandez-Prat A, Hernandez-Llodra S, Rovira A, Juan O, et al. Dual mTOR1\/2 inhibitor sapanisertib (FTH-003\/TAK-228) in combination with weekly Paclitaxel in patients with previously treated metastatic urothelial carcinoma: A phase II Open-Label study. Clin Genitourin Cancer. 2024;22(5):102123.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"4157_CR9","first-page":"e310323215268","volume":"17","author":"R Basnet","year":"2024","unstructured":"Basnet R, Bahadur Basnet B, Gupta R, Basnet T, Khadka S, Shan Alam M. Mammalian target of Rapamycin (mTOR) signalling Pathway-A potential target for cancer intervention: A short overview. Curr Mol Pharmacol. 2024;17(1):e310323215268.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"4157_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1378\/chest.13-1071","volume":"145","author":"X Cai","year":"2014","unstructured":"Cai X, Pacheco-Rodriguez G, Haughey M, Samsel L, Xu S, Wu HP, McCoy JP, Stylianou M, Darling TN, Moss J. Sirolimus decreases Circulating Lymphangioleiomyomatosis cells in patients with Lymphangioleiomyomatosis. Chest. 2014;145(1):108\u201312.","journal-title":"Chest"},{"issue":"1","key":"4157_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2023.02.026","volume":"164","author":"W Xu","year":"2023","unstructured":"Xu W, Yang C, Cheng C, Wang Y, Hu D, Huang J, He Y, Wang J, Chen K, Yang L, et al. Determinants of progression and mortality in Lymphangioleiomyomatosis. Chest. 2023;164(1):137\u201348.","journal-title":"Chest"},{"issue":"6","key":"4157_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","volume":"194","author":"FX McCormack","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, Steagall WK, Johnson SR, Sahn SA, Ryu JH, et al. Official American thoracic society\/Japanese respiratory society clinical practice guidelines: Lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016;194(6):748\u201361.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4157_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/thoraxjnl-2017-211135","volume":"73","author":"KF Xu","year":"2018","unstructured":"Xu KF, Tian X, Yang Y, Zhang H. Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage. Thorax. 2018;73(4):308\u201310.","journal-title":"Thorax"},{"issue":"17","key":"4157_CR14","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, et al. Efficacy and safety of sirolimus in Lymphangioleiomyomatosis. N Engl J Med. 2011;364(17):1595\u2013606.","journal-title":"N Engl J Med"},{"issue":"9","key":"4157_CR15","doi-asserted-by":"publisher","first-page":"e0201005","DOI":"10.1371\/journal.pone.0201005","volume":"13","author":"JJ Bissler","year":"2018","unstructured":"Bissler JJ, Nonomura N, Budde K, Zonnenberg BA, Fischereder M, Voi M, Louveau AL, Herbst F, Bebin EM, Curatolo P, et al. Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic Lymphangioleiomyomatosis. PLoS ONE. 2018;13(9):e0201005.","journal-title":"PLoS ONE"},{"issue":"1","key":"4157_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.00076209","volume":"35","author":"SR Johnson","year":"2010","unstructured":"Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, Reynaud-Gaubert M, Boehler A, Brauner M, Popper H, et al. European respiratory society guidelines for the diagnosis and management of Lymphangioleiomyomatosis. Eur Respir J. 2010;35(1):14\u201326.","journal-title":"Eur Respir J"},{"issue":"2","key":"4157_CR17","first-page":"92","volume":"42","author":"Interstitial Lung Disease Group CTS, Chinese Medical Association","year":"2019","unstructured":"Interstitial Lung Disease Group CTS, Chinese Medical Association. [Consensus statement: sirolimus (rapamycin) as therapy for Lymphangioleiomyomatosis (2018)]. Zhonghua Jie he he Hu Xi Za zhi\u2009=\u2009Zhonghua Jiehe he Huxi Zazhi\u2009=\u2009Chinese. J Tuberculosis Respiratory Dis. 2019;42(2):92\u20137.","journal-title":"J Tuberculosis Respiratory Dis"},{"issue":"1","key":"4157_CR18","first-page":"59","volume":"15","author":"M Krousel-Wood","year":"2009","unstructured":"Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59\u201366.","journal-title":"Am J Manag Care"},{"issue":"9","key":"4157_CR19","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s10067-022-06195-y","volume":"41","author":"PL Shi","year":"2022","unstructured":"Shi PL, Wu ZZ, Wu L, Gao RC, Wu ZG, Wu GC. Reliability and validity of the Chinese version of the eight-item Morisky medication adherence scale in Chinese patients with systemic lupus erythematosus. Clin Rheumatol. 2022;41(9):2713\u201320.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4157_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","volume":"60","author":"E Broadbent","year":"2006","unstructured":"Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631\u20137.","journal-title":"J Psychosom Res"},{"issue":"3","key":"4157_CR21","doi-asserted-by":"publisher","first-page":"e0174093","DOI":"10.1371\/journal.pone.0174093","volume":"12","author":"N Zhang","year":"2017","unstructured":"Zhang N, Fielding R, Soong I, Chan KK, Lee C, Ng A, Sze WK, Tsang J, Lee V, Lam WW. Psychometric assessment of the Chinese version of the brief illness perception questionnaire in breast cancer survivors. PLoS ONE. 2017;12(3):e0174093.","journal-title":"PLoS ONE"},{"key":"4157_CR22","first-page":"98","volume":"2","author":"SY X","year":"1994","unstructured":"SY X. Theoretical basis and research application of social support rating scale. J Clin Psychiatry. 1994;2:98\u2013100.","journal-title":"J Clin Psychiatry"},{"key":"4157_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29.","journal-title":"Health Qual Life Outcomes"},{"key":"4157_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejon.2016.09.004","volume":"25","author":"Q Li","year":"2016","unstructured":"Li Q, Lin Y, Hu C, Xu Y, Zhou H, Yang L, Xu Y. The Chinese version of hospital anxiety and depression scale: psychometric properties in Chinese cancer patients and their family caregivers. Eur J Oncol Nurs. 2016;25:16\u201323.","journal-title":"Eur J Oncol Nurs"},{"issue":"11","key":"4157_CR25","first-page":"1609","volume":"11","author":"AM Garc\u00eda-Mu\u00f1oz","year":"2023","unstructured":"Garc\u00eda-Mu\u00f1oz AM, Victoria-Montesinos D, Cerd\u00e1 B, Ballester P, de Velasco EM, Zafrilla P. Self-Reported medication adherence measured with Morisky scales in rare disease patients: A systematic review and Meta-Analysis. Healthc (Basel). 2023;11(11):1609.","journal-title":"Healthc (Basel)"},{"issue":"8","key":"4157_CR26","doi-asserted-by":"publisher","first-page":"e0237710","DOI":"10.1371\/journal.pone.0237710","volume":"15","author":"RA Afaya","year":"2020","unstructured":"Afaya RA, Bam V, Azongo TB, Afaya A, Kusi-Amponsah A, Ajusiyine JM, Abdul Hamid T. Medication adherence and self-care behaviours among patients with type 2 diabetes mellitus in Ghana. PLoS ONE. 2020;15(8):e0237710.","journal-title":"PLoS ONE"},{"issue":"1","key":"4157_CR27","doi-asserted-by":"publisher","first-page":"19118","DOI":"10.1038\/s41598-024-70000-w","volume":"14","author":"M Amerzadeh","year":"2024","unstructured":"Amerzadeh M, Shafiei Kisomi Z, Senmar M, Khatooni M, Hosseinkhani Z, Bahrami M. Self-care behaviors, medication adherence status, and associated factors among elderly individuals with type 2 diabetes. Sci Rep. 2024;14(1):19118.","journal-title":"Sci Rep"},{"key":"4157_CR28","doi-asserted-by":"publisher","first-page":"1283416","DOI":"10.3389\/fpubh.2023.1283416","volume":"11","author":"A Wang","year":"2023","unstructured":"Wang A, Wan J, Zhu L, Chang W, Wen L, Tao X, Jin Y. Frailty and medication adherence among older adult patients with hypertension: a moderated mediation model. Front Public Health. 2023;11:1283416.","journal-title":"Front Public Health"},{"issue":"2","key":"4157_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/hed.26488","volume":"43","author":"P Bas\u0131m","year":"2021","unstructured":"Bas\u0131m P, Argun D, \u00d6zdenkaya Y. Self-reported medication adherence in differentiated thyroid cancer survivors: role of illness perception and medication beliefs. Head Neck. 2021;43(2):428\u201337.","journal-title":"Head Neck"},{"key":"4157_CR30","doi-asserted-by":"publisher","first-page":"109289","DOI":"10.1016\/j.yebeh.2023.109289","volume":"145","author":"H Choi","year":"2023","unstructured":"Choi H, Wetmore JB, Camarillo IA, Misiewicz S, Siegel K, Chung WK, Leu CS, Phelan JC, Yang LH, Ottman R. Association of Antiseizure medication adherence with illness perceptions in adults with epilepsy. Epilepsy Behav. 2023;145:109289.","journal-title":"Epilepsy Behav"},{"key":"4157_CR31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2147\/PPA.S266871","volume":"14","author":"C Liu","year":"2020","unstructured":"Liu C, Tham CW, De Roza J, Chong BY, Koh YL, Tan NC. The association between beliefs and adherence to inhaled controller medication among older adults with asthma: A Cross-Sectional study in primary care. Patient Prefer Adherence. 2020;14:1351\u20139.","journal-title":"Patient Prefer Adherence"},{"key":"4157_CR32","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.2147\/COPD.S543458","volume":"20","author":"LJA Cuperus","year":"2025","unstructured":"Cuperus LJA, De Jong G, Bischoff E, Van Boven JFM, Van der Palen J, Aerts J, Kerstjens HAM. In\u2019t Veen J: adherence to inhaled medication guidelines in patients with COPD: evaluating the GOLD 2023 strategy in a Real-World secondary care setting. Int J Chron Obstruct Pulmon Dis. 2025;20:3877\u201391.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"4157_CR33","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1183\/09031936.00172114","volume":"45","author":"AL Dima","year":"2015","unstructured":"Dima AL, Hernandez G, Cunillera O, Ferrer M, de Bruin M. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J. 2015;45(4):994\u20131018.","journal-title":"Eur Respir J"},{"issue":"2","key":"4157_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, et al. Sirolimus for Angiomyolipoma in tuberous sclerosis complex or Lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):140\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"4157_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13023-018-0946-8","volume":"13","author":"HY Yoon","year":"2018","unstructured":"Yoon HY, Hwang JJ, Kim DS, Song JW. Efficacy and safety of low-dose sirolimus in Lymphangioleiomyomatosis. Orphanet J Rare Dis. 2018;13(1):204.","journal-title":"Orphanet J Rare Dis"},{"key":"4157_CR36","doi-asserted-by":"publisher","first-page":"2024-5-2","DOI":"10.7573\/dic.2024-5-2","volume":"13","author":"P Agrawal","year":"2024","unstructured":"Agrawal P, Patrick S, Thomas M, Gupta D, Singh Matreja P, Singh P, Zafar S. Pharmacovigilance monitoring and treatment adherence in patients on antihypertensive drugs at a tertiary care centre. Drugs Context. 2024;13:2024-5-2.","journal-title":"Drugs Context"},{"key":"4157_CR37","doi-asserted-by":"publisher","first-page":"109029","DOI":"10.1016\/j.yebeh.2022.109029","volume":"138","author":"F Narducci","year":"2023","unstructured":"Narducci F, Lanzone J, Ricci L, Marrelli A, Piccioli M, Boscarino M, Vico C, Sancetta B, Di Lazzaro V, Tombini M, et al. Determinants of medication adherence in people with epilepsy: A multicenter, cross-sectional survey. Epilepsy Behav. 2023;138:109029.","journal-title":"Epilepsy Behav"},{"issue":"9","key":"4157_CR38","first-page":"e70397","volume":"16","author":"S Al-Chawishli","year":"2024","unstructured":"Al-Chawishli S, Dizaye K, Azeez S. Measuring diabetic medication adherence and factors that lead to Non-adherence among patients in Erbil. Cureus. 2024;16(9):e70397.","journal-title":"Cureus"},{"key":"4157_CR39","doi-asserted-by":"publisher","first-page":"730845","DOI":"10.3389\/fpubh.2021.730845","volume":"9","author":"J Huang","year":"2021","unstructured":"Huang J, Ding S, Xiong S, Liu Z. Medication adherence and associated factors in patients with type 2 diabetes: A structural equation model. Front Public Health. 2021;9:730845.","journal-title":"Front Public Health"},{"issue":"2","key":"4157_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00330-019-06412-4","volume":"30","author":"C Kim","year":"2020","unstructured":"Kim C, Do KH, Cha J, Song JW, Lee SM, Lee KY. Effects of sirolimus in Lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study. Eur Radiol. 2020;30(2):735\u201343.","journal-title":"Eur Radiol"},{"issue":"12","key":"4157_CR41","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","volume":"154","author":"AM Taveira-DaSilva","year":"2011","unstructured":"Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J. Changes in lung function and chylous effusions in patients with Lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med. 2011;154(12):797\u2013805. w-292-793.","journal-title":"Ann Intern Med"},{"issue":"11","key":"4157_CR42","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","volume":"190","author":"J Yao","year":"2014","unstructured":"Yao J, Taveira-DaSilva AM, Jones AM, Julien-Williams P, Stylianou M, Moss J. Sustained effects of sirolimus on lung function and cystic lung lesions in Lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2014;190(11):1273\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4157_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/thoraxjnl-2017-210872","volume":"73","author":"J Bee","year":"2018","unstructured":"Bee J, Fuller S, Miller S, Johnson SR. Lung function response and side effects to Rapamycin for lymphangioleiomyomatosis: a prospective National cohort study. Thorax. 2018;73(4):369\u201375.","journal-title":"Thorax"},{"issue":"11","key":"4157_CR44","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1513\/AnnalsATS.201605-335OC","volume":"13","author":"T Takada","year":"2016","unstructured":"Takada T, Mikami A, Kitamura N, Seyama K, Inoue Y, Nagai K, Suzuki M, Moriyama H, Akasaka K, Tazawa R, et al. Efficacy and safety of Long-Term sirolimus therapy for Asian patients with Lymphangioleiomyomatosis. Ann Am Thorac Soc. 2016;13(11):1912\u201322.","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"4157_CR45","doi-asserted-by":"publisher","first-page":"1802066","DOI":"10.1183\/13993003.02066-2018","volume":"53","author":"N Gupta","year":"2019","unstructured":"Gupta N, Lee HS, Young LR, Strange C, Moss J, Singer LG, Nakata K, Barker AF, Chapman JT, Brantly ML et al. Analysis of the MILES cohort reveals determinants of disease progression and treatment response in Lymphangioleiomyomatosis. Eur Respir J. 2019;53(4):1802066.","journal-title":"Eur Respir J"},{"issue":"1","key":"4157_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13023-019-1178-2","volume":"14","author":"S Hu","year":"2019","unstructured":"Hu S, Wu X, Xu W, Tian X, Yang Y, Wang ST, Liu S, Xu X, Xu KF. Long-term efficacy and safety of sirolimus therapy in patients with Lymphangioleiomyomatosis. Orphanet J Rare Dis. 2019;14(1):206.","journal-title":"Orphanet J Rare Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04157-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04157-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04157-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:02:19Z","timestamp":1774886539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04157-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04157-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publications were obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Second Xiangya Hospital of Central South University (Ethical Code: LYEC2024-0141). Informed consent was obtained from all individual participants included in the study. The study was conducted in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval<!--Emphasis Type='Bold' removed-->and informed consent."}}],"article-number":"141"}}